These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 9845852
1. Diet and pravastatin in moderate hypercholesterolaemia: a randomized trial in 215 middle-aged men free from cardiovascular disease. Bak AA, Huizer J, Leijten PA, Rila H, Grobbee DE. J Intern Med; 1998 Nov; 244(5):371-8. PubMed ID: 9845852 [Abstract] [Full Text] [Related]
4. Treating hypercholesterolaemia with HMG CoA reductase inhibitors: a direct comparison of simvastatin and pravastatin. Lintott CJ, Scott RS, Sutherland WH, Bremer J. Aust N Z J Med; 1993 Aug; 23(4):381-6. PubMed ID: 8240151 [Abstract] [Full Text] [Related]
5. Treatment of primary hypercholesterolaemia. Short-term efficacy and safety of increasing doses of simvastatin and pravastatin: a double-blind comparative study. Stalenhoef AF, Lansberg PJ, Kroon AA, Kortmann B, De Haan AF, Stuyt PM, Kastelein JJ. J Intern Med; 1993 Jul; 234(1):77-82. PubMed ID: 8326293 [Abstract] [Full Text] [Related]
6. Effect of pravastatin on body composition and markers of cardiovascular disease in HIV-infected men--a randomized, placebo-controlled study. Mallon PW, Miller J, Kovacic JC, Kent-Hughes J, Norris R, Samaras K, Feneley MP, Cooper DA, Carr A. AIDS; 2006 Apr 24; 20(7):1003-10. PubMed ID: 16603852 [Abstract] [Full Text] [Related]
7. Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. I. A dose-response study. Hunninghake DB, Knopp RH, Schonfeld G, Goldberg AC, Brown WV, Schaefer EJ, Margolis S, Dobs AS, Mellies MJ, Insull W. Atherosclerosis; 1990 Nov 24; 85(1):81-9. PubMed ID: 2126437 [Abstract] [Full Text] [Related]
10. Pravastatin and risk factor modification in patients with moderate primary hypercholesterolaemia. Morris R, Robinson G, Tilyard M, Gurr E. N Z Med J; 1996 Aug 23; 109(1028):319-22. PubMed ID: 8816723 [Abstract] [Full Text] [Related]
11. Cholesteryl ester transfer in hypercholesterolaemia: fasting and postprandial studies with and without pravastatin. Contacos C, Barter PJ, Vrga L, Sullivan DR. Atherosclerosis; 1998 Nov 23; 141(1):87-98. PubMed ID: 9863541 [Abstract] [Full Text] [Related]
14. Effects of fluvastatin and pravastatin on lipid profiles and thromboxane production in type IIa hypercholesterolemia. Milani M, Cimminiello C, Merlo B, Lorena M, Arpaia G, Bonfardeci G. Am J Cardiol; 1995 Jul 13; 76(2):51A-53A. PubMed ID: 7604798 [Abstract] [Full Text] [Related]
17. Pharmacokinetics of pravastatin in heart-transplant patients taking cyclosporin A. Park JW, Siekmeier R, Merz M, Krell B, Harder S, März W, Seidel D, Schüler S, Gross W. Int J Clin Pharmacol Ther; 2002 Oct 13; 40(10):439-50. PubMed ID: 12395976 [Abstract] [Full Text] [Related]
18. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial. Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW, Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group. Clin Ther; 2004 Sep 13; 26(9):1388-99. PubMed ID: 15531001 [Abstract] [Full Text] [Related]